ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
ADMA Biologics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
ADMA Biologics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at ADMA Biologics received on average a compensation package of $2.6M, a 84% increase compared to previous year.
Average pay of disclosed executives at ADMA Biologics
Adam S. Grossman, Chief Executive Officer, received $4.4M in total, which increased by 122% compared to 2020. 53% of Grossman's compensation, or $2.3M, was in stock awards. Grossman also received $731K in bonus, $674K in option awards, $618K in salary, as well as $43K in other compensation.
Brian Lenz, Chief Financial Officer, received a compensation package of $2.4M, which increased by 118% compared to previous year. 48% of the compensation package, or $1.1M, was in stock awards.
James Mond, Chief Scientific Officer, earned $1.1M in 2021, a 8% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.